Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Individuals with diabetes characterized by HbA1c 6.5%, or a history of surgical or device-based obesity treatment, were excluded
To assist with making a comparison, heres a table displaying peptide therapy and common methods side by side
Back Tschp, MH, Finan, B, Clemmensen, C, et al (July 2016) 'Unimolecular polypharmacy for treatment of diabetes and obesity', Cell Metabolism , 24, 51-62
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
It also has a distinctive regulatory position: it was previously an FDA-approved product (marketed as Geref, a diagnostic agent) before being voluntarily withdrawn from the market, and that prior-approval history has given it a more stable standing for compounding than most other peptides
US$ 26.76
US$ 28.43
US$ 23.00
US$ 20.39
